In situations of metabolic syndrome and diabetes, TGF-β signaling is systemically activated as the serum levels of TGF-β1 are elevated in patients with obesity and diabetic animal models along with increased levels of p-Smad2/3 in various tissues [34,35,36]. Here, TGFB1 is linked to obesity due to melanocortin 4 receptor deficiency.